Screening forp53 mutations in c3h/he mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone
- 1 February 1994
- journal article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 9 (2) , 71-75
- https://doi.org/10.1002/mc.2940090204
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- PCR-SSCP: A method for detection of mutationsGenetic Analysis: Biomolecular Engineering, 1992
- Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylintrosamine or phenobarbitoneCarcinogenesis: Integrative Cancer Research, 1991
- p53 Mutations in Human CancersScience, 1991
- Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.Proceedings of the National Academy of Sciences, 1991
- Activated Oncogenes in B6C3F1 Mouse Liver Tumors: Implications for Risk AssessmentScience, 1987
- The Histopathology and Biochemistry of Phenobarbitone-Induced Liver Nodules in C3H MicePublished by Springer Nature ,1987
- Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse.Proceedings of the National Academy of Sciences, 1986
- The histology and development of hepatic nodules in C3H/He mice following chronic administration of phenobarbitoneCarcinogenesis: Integrative Cancer Research, 1986
- Cooperation between gene encoding p53 tumour antigen and ras in cellular transformationNature, 1984
- Sustained induction of hepatic xenobiotic metabolising enzyme activities by phenobarbitone in C3H/He mice: Relevance to nodule formationToxicology, 1984